FDA Faces Multiple Challenges

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2005
Volume 29
Issue 9

Commissioner Crawford’s top priority is to restore public confidence in FDA oversight of drug safety and quality.

External Link - article-178589.pdf

Articles in this issue
i1_t-179357-1408683578893.gif
Securing the Supply Chain With RFID
Applications of Poly(ethylene in Drug Delivery Systems: Part II
Analytical Method Equivalency: An Acceptable Analytical Practice
The Nation Needs a Comprehensive Pharmaceutical Engineering Education and Research System
September 2005
Pilots and Partnerships Move RFID Forward
Reshaping CMC Development Services
Wash. Rinse. Repeat
i2-179358-1408683576722.gif
Artificial Distinctions: Protein A Mimetic Ligands for Bioprocess Separations
i1-179351-1408683585762.jpg
Outsourcing Atrophy: A Cautionary Tale
In the Spotlight-September 2005
FDA Faces Multiple Challenges
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com

FDA Posts Slate of Seven Warning Letters Following Company Inspections

Patrick Lavery
June 12th 2025
Article

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. | Image source: ©huiying - stock.adobe.com

ICH Q6B for Analytics

Richard Easton;Christopher Ziegenfuss
June 6th 2025
Article

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

EMA Is Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals

Cheryl Barton
June 4th 2025
Article

EMA has published recommendations to address potential radiopharmaceutical shortages.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Guidance on Quality Culture Standards

Matt Cushing;Susan J. Schniepp
June 3rd 2025
Article

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.